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a  b  s  t  r  a  c  t
INTRODUCTION:  Hemangiopericytomas  (HPCs)  are  rare  vascular  tumors  with  a high  malignant  potential.
Hepatic  metastases  from  HPC  are  very  infrequent  and  usually  show  a  distinctive  solid aspect  with  a
surrounding  pseudocapsule.
PRESENTATION OF  CASE:  A 37-year-old  man  with  a previous  medical  history  of  recurrent  spinal  heman-
giopericytoma  with  a  9  cm ×  7  cm cystic  hepatic  mass  detected  on follow-up.  Contrast  enhanced  US  and
MRI  conﬁrmed  the  presence  the  lesion  showing  mixed  (solid  and  cystic)  content.  Parasitic  and  viral
serology  plus  serum  tumoral  markers  (CEA,  ca  19.9,  ca 125,  AFP)  tests,  upper  and  lower  endoscopy  and
general  laboratory  tests  were  normal  and  extended  left lobectomy  was  performed.  Histopathologic  study
conﬁrmed  the  diagnosis  of multifocal  metastasic  hemangiopericytoma  with  moderate  CD-34,  CD-99  and
Bcl-2  positivity  after  immunohistochemical  staining.  After  1-year  follow-up  the  patient  does  not  present
any  evidence  of  abdominal  recurrence  but a skull  base  recurrence  has  been  detected.
DISCUSSION: Liver  metastasis  from  spinal  HPC  are  uncommon  and  do  not  have  cystic  appearance  so
radiologic  diagnosis  can  be  challenging.  In spite  of  the  presence  of  previously  diagnosed  HPC  context,
the  presence  of  a liver  cystic  mass  in a young  patient  makes  necessary  to discard  a number  much  more
frequent  benign  and  malignant  diagnosis  before  metastatic  disease  can  be conﬁrmed.
CONCLUSION: The  presence  of  a cystic  hepatic  mass  makes  it mandatory  to rule out  a number  neoplasms
other  than  metastasic  HPC  before  a deﬁnitive  diagnosis  is  made.  In  addition  to  local  radiotherapy  and
antiangiogenic  agents,  surgery  can  be  useful  to  treat liver  dissemination.
gical © 2012 Sur
. Introduction
Hemangiopericytomas (HPCs) are rare vascular tumors with a
igh malignant potential due to their capacity of local recurrence
nd dissemination.1 Although liver dissemination is not an uncom-
on feature of these neoplasms, hepatic metastases from HPC are
ery infrequent and usually show a distinctive solid aspect with a
urrounding pseudocapsule.2 We  present the case of a 37-year-old
ith a previous history of recurrent spinal HPC who was  referredo our Hospital after a liver cystic mass was detected. The pres-
nce of a liver cystic mass in a young patient makes it necessary
o discard a number much more frequent benign and malignant
Abbreviations: HPC, hemangiopericytoma; MRI, magnetic resonance imaging;
T,  computed tomography; US, ultrasonography.
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diagnosis before metastatic HPC can be conﬁrmed.3 Also, the clin-
ical aspects diagnostic difﬁculties, pathological characterization,
and therapeutic strategies are discussed.
2. Case presentation
A  37-year-old Caucasian man  with a previous history of mul-
tifocal recurrent spinal HPC diagnosed in 1994 was  admitted to
our institution. The patient underwent surgery plus local radio-
therapy at the time of the diagnosis and remained free of disease
until 2000 when local recurrence was  detected and treated effec-
tively. Subsequently he developed more local relapses in 2001,
2001 and 2007 that were treated with focal radiotherapy. In 2008
another lesion at the 10th dorsal vertebral body was  surgically
removed and adjuvant radiotherapy was  again administrated. The
patient remained asymptomatic until a hepatic cystic mass was
detected in a routine spine MRI  on follow-up. Abdominal ultra-
Open access under CC BY-NC-ND license.sound revealed a 96 mm × 65 mm  septated cystic mass in segments
II–III of the liver with well-deﬁned borders. Hepatic MRI  conﬁrmed
a 9.4 cm × 7.8 cm × 11 cm mass with mixed (solid and cystic) con-
tent, irregular septa and several hemorrhagic foci. When contrast
 BY-NC-ND license.
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Fig. 3. CD-34 staining. Tumoral cells showing moderate CD-34 positivity after
immunohistochemical staining.ig. 1. T2-weighted hepatic MRI. Picture shows a 9.4 cm × 7.8 cm × 11 cm mass with
ystic and solid components with irregular septa.
as administrated, both septa and solid areas showed progressive
nhancement (Fig. 1).
Differential  diagnosis between a hydatid cyst versus primary or
etastatic hepatic neoplasm was considered. Results for parasitic
nd viral serology plus serum tumoral markers (CEA, ca 19.9, ca
25, AFP) tests, upper and lower endoscopy and general laboratory
ests were normal.
Due  to the previous medical history, exploratory laparotomy
as decided. A left hepatic bisegmentectomy extended to IVb was
erformed (Fig. 2). The postoperative course was uneventful and
he patient was discharged seven days after surgery. Histopatho-
ogic study identiﬁed not only the radiologicaly identiﬁed mass that
easured 108 mm × 63 mm × 58 mm mass but also two  less than
 cm subcapsular masses, they were all compatible with metastatic
PC. Resection borders were not affected and immunohistochemi-
al staining of the tumoral cells showed moderate CD-34, CD-99
nd Bcl-2 positivity (Figs. 3–5). After evaluation by our Institu-
ion’s Oncology Department the patient did not received adjuvant
reatment. After 1-year follow-up including CT and PET-CT scans,
ig. 2. Surgical specimen. Macroscopic appearance of the surgical specimen after
epatic II–III bisegmentectomy (extended to IVb) was  performed.
Fig. 4. CD-99 staining. Tumoral cells showing mild CD-99 positivity after immuno-
histochemical  staining.
Fig. 5. Bcl-2 staining. Tumoral cells showing positivity for Bcl-2CD-99 after
immunohistochemical staining.
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he patient remained and asymptomatic without any evidence of
bdominal recurrence. However a new spinal (L5-S1) recurrence
as diagnosed.
.  Discussion
HPCs are borderline tumors that arise from contractile cells
urrounding venula and capillary vessels.4 It represents less than
% of all primary vascular neoplasms and typically presents
t the 5th decade of life. They are slightly more frequent in
en and most reported locations are in the lower extremities
nd retroperitoneum.1,2 More than 64% of the patients show
 high local-recurrence rate or long-term distant metastases.
hus, a high malignant potential is one of the hallmarks of
his neoplasm.5 Approximately 75% of these tumors are malig-
ant and 25% are considered borderline or with low-malignant
otential.2 Pathological diagnosis of HPC can be difﬁcult and
ome subtypes (lipomatous HPC) can be missdiagnosed as other
oft tissue tumors.1,6 Moreover, there is not a well-deﬁned
istopathologic classiﬁcation for this kind of tumors, and malig-
ancy is mostly determined by their clinical behavior. Lungs,
iver and bone are the most common locations for dissemina-
ion. Other rare intraabdominal locations are greater omentum,
pleen, large bowel or peritoneum.7 Liver metastases from HPC
sually debut as asymptomatic masses which are detected during
ollow-up. However, because of IGF-2 expression, severe hypo-
lycemias have been described. Long-term survival for metastatic
emangipericytoma is highly variable and ranges from 40 to
5%.1,5
Hepatic metastases of HPC are usually detected by contrast-
nhanced US, MRI  or angiography.8,9 The average diameter at
iagnosis is 6.5 cm and usually they present as a hypervascular,
ncapsulated solid lesion, in contrast to the cystic appearance of
he case lesion. To the best of our knowledge, this is the ﬁrst time
hat this feature has been reported. The differential diagnosis of
ystic hepatic mass includes, primary lesions such as simple cysts,
ystoadenoma and cystoadenocarcinoma.3 In areas with a high
revalence of Echinococcus sp. infestation, the possibility of hydatic
ysts must also be ruled out. On the other hand, the presence of
 previous vascular malignancy and the radiographic features of
 hepatic mass made it necessary to rule out a secondary tumor.
lthough some authors have employed ultrasound-guided ﬁne
eedle aspiration biopsy, the results can be very variable and a
ifferential diagnosis with other benign tumors can be difﬁcult.10
oreover, percutaneous or incisional biopsy is a diagnostic tool
ut it is not recommended when a metastatic HPC is suspected
eware of its hypervascularization, thus making excisional biopsy
andatory.
Late metastases are characteristic and can appear even after
0 years after complete remission of the primary tumor.5 In our
atient, the liver metastases appeared 15 years after the initial
iagnosis. More than 11% of the histological malignant tumors and
% of those considered as borderline malignancy showed distant
etastasis within the ﬁrst 5 years after clinically or radiologically
onﬁrmed complete remission.2,5 Nevertheless, hypercellularity,
ncreased mitotic activity, cellular anaplasia and extense necrotic
r hemorrhagic areas are related to a higher malignant potential
nd worse prognosis. Our patient showed a CD-34 and Blc-2 pos-
tive cellular pattern. Positivity to CD-34 is a common feature of
ntracranial and spinal HPCs and has also been described in dis-
eminated disease. However, it does not play a pivotal role in HPC
iagnosis.11 Although there is no evidence to support the relation-
hip between these markers and a more aggressive behavior, their
resence could be considered as high-rate replication signs and
ossibly high chance of recurrence.PEN  ACCESS
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Surgery plus radiotherapy are considered as the gold standard
for primary HPCs. However, the treatment of metastatic hepatic
disease is not well established because of the lack of large clinical
series. Liver metastases are usually treated by surgery following
oncologic principles. In addition, there is very limited experience
using adjuvant therapy like chemotherapy, radiation or anti-
angiogenic agents with a variable and unpredictable response.12
Liver transplantation has also been proposed in strictly selected
cases, specially those with untreatable hypoglycemia due to
paraneoplasic IGF-2 release.13 Less invasive approaches such as
radio-guided embolization have been proposed but there is not
enough experience to determine its effectiveness in managing
these neoplasms.14
4. Conclusions
Liver metastases from spinal HPCs are frequent long-term man-
ifestations which usually present with well-deﬁned clinical and
radiographic features. Cystic lesions with irregular septa have not
been reported previously. The presence of a cystic hepatic mass
makes it mandatory to rule out a number of primary and secondary
neoplasms other than metastasic HPC before a deﬁnitive diagnosis
is made. Although the primary disease could be difﬁcult to cure
because of the high local recurrence rate, surgery can be useful to
treat liver metastasis from these tumors.
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